Precision System Science Co., Ltd.
Stock Price Chart
2026/08/21 UpdatedPrice Trend
2026/08/21 UpdatedPrice & Trading Details
2026/08/21 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
SPDR Portfolio Developed World ex-US ETF
|
34.7K | 0.00% |
Dividend History
Updated 2026/08/16| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥2 | -60.0% |
| 2021 | ¥5 | -33.3% |
| 2014 | ¥8 | -34.8% |
| 2013 | ¥12 | +53.3% |
| 2010 | ¥8 | - |
Financial Performance
2026/08/16 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Income Statement | |||
| Revenue | ¥7,434M | ¥5,278M | ¥3,980M |
| Gross Profit | ¥2,487M | ¥1,350M | ¥950M |
| Operating Income | ¥152M | -¥1,112M | -¥956M |
| Pretax Income | ¥206M | -¥1,235M | -¥1,071M |
| Net Income | ¥45M | -¥1,324M | -¥1,121M |
| EPS | ¥1.64 | -¥47.93 | - |
| Operating Margin | 2.05% | -21.08% | -24.03% |
| Balance Sheet | |||
| Total Assets | ¥11,410M | ¥9,762M | ¥6,397M |
| Total Equity | ¥6,512M | ¥5,222M | ¥4,143M |
| Total Liabilities | ¥4,898M | ¥4,539M | ¥2,254M |
| Cash | ¥2,764M | ¥2,446M | ¥1,915M |
| Interest-bearing Debt | ¥4,019M | ¥3,866M | ¥1,367M |
| Equity Ratio | 57.07% | 53.50% | 64.77% |
| D/E Ratio | 0.62 | 0.74 | 0.33 |
| Cash Flow | |||
| Operating CF | ¥869M | -¥7M | -¥107M |
| Investing CF | -¥2,285M | -¥214M | ¥2,057M |
| Financing CF | ¥94M | -¥154M | -¥2,508M |
| Free CF | -¥1,380M | -¥162M | -¥131M |
| Efficiency | |||
| ROE | 0.70% | -25.36% | -27.07% |
| ROA | 0.40% | -13.57% | -17.53% |
Latest IR Information
-
Financial Results Briefing Materials for the Fiscal Year Ending June 2026
For the fiscal year ending June 2026, the company returns to profitability on a consolidated basis. The summary covers the actual results for the year ended June 2026, the outlook for the year ending June 2027, progress of the PSS...
Read more -
(Correction) Notice regarding partial correction of the Financial Summary (Consolidated) for the fiscal year ending June 2026
Partial correction to the Financial Summary for the fiscal year ending June 2026. The corrected components of the revenue mix are shown with underlining; the composition ratios and amounts for Equipment, Reagents & Consumables, Services & Others have been revised.
Read more -
Precision System Science Corporation 2026 June Term Financial Summary
Sales of 5,216 million yen (YoY +11.2%), operating income turned positive at 201 million yen, net income attributable to owners of the parent improved to 394 million yen. For the year ending June 2027, sales are expected to be 5,650...
Read more
Latest News (5 items)
Company Information
About
Precision System Science Co., Ltd., together with its subsidiaries, engages in the development, manufacturing, and sale of automated systems/instruments, other physicochemical instruments, software, and other products in Japan. It also offers geneLEAD series; extraction reagents for nucleic acid extraction and biochemical testing; and LecChip series products. In addition, the company manufactures and sells reagents, as well as plastic consumables for use in the automated system/instruments. Its products are used in research and development, and practical application of in vitro diagnosis testing market, including genetic and protein tests. Precision System Science Co., Ltd. was incorporated in 1985 and is headquartered in Matsudo, Japan.
